Retroviral restriction factors TRIM5α: Therapeutic strategy to inhibit HIV-1 replication

Current Medicinal Chemistry

Volumn 18, Issue 17, 2011, Pages 2649-2654

  Zhang, Jing ^a   Ge, Weiying ^a   Zhan, Peng ^a   De Clercq, Erik ^b   Liu, Xinyong ^a  

^a SHANDONG UNIVERSITY   (China)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Cyp A; Gene therapy; HIV 1; Mechanism; TRIM5

Indexed keywords

CAPSID PROTEIN; CYCLOPHILIN A; MUTANT PROTEIN; TRIPARTITE MOTIF PROTEIN 5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; GENE THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PATHOGENESIS; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RETROVIRUS; REVERSE TRANSCRIPTION; VIRUS INHIBITION; VIRUS RESISTANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CARRIER PROTEINS; CYCLOPHILIN A; GENE THERAPY; HIV-1; HUMANS; MACACA MULATTA; VIRUS REPLICATION; VIRUS UNCOATING;

EID: 79957937058     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711795933687     Document Type: Article

References (65)

1. Bieniasz, P. D. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol., 2004, 5, 1109-1115. (Pubitemid 39549624)
2. Emerman, M. How TRIM5alpha defends against retroviral invasions. Proc. Natl. Acad. Sci. U S A, 2006, 103, 5249-5250.
3. Song, B. TRIM5alpha. Curr. Top. Microbiol. Immunol., 2009, 339, 47-66.
4. Stremlau, M.; Owens, C.M.; Perron1, M.J.; Kiessling, M.; Autissier, P.; Sodroski, J. The cytoplasmic body component TRIM5- are stricts HIV-1 infection in Old World monkeys. Nature, 2004, 427, 848-853.
5. Reymond, A.; Meroni, G.; Fantozzi, A.; Merla, G.; Cairo, S.; Luzi, L.; Riganelli, D.; Zanaria, E.; Messali, S.; Cainarca, E.; Guffanti, A.; Minucci, S.; Pelicci, P.G.; Ballabio, A. The tripartite motif family identifies cell compartments. EMBO J., 2001, 20, 2140-2151. (Pubitemid 32410584)
6. Javanbakht, H.; Diaz-Griffer, F.; Stremlau, M.; Si, Z.H.; Sodroski, J. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J. Biol. Chem., 2005, 280, 26933-26940. (Pubitemid 41040729)
7. Maegawa, H.; Miyamoto, T.; Sakuragi, J.; Shioda, T.; Nakayama, E.E. Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus. Virology, 2010, 399, 212-220.
8. Diaz-Griffero, F.; Kar, A.; Perron, M.; Xiang, S.H.; Javanbakht, H.; Li, X.; Sodroski, J. Modulation of retroviral restriction and proteasome inhibitorresistant turnover by changes in the TRIM5alpha B-box 2 domain. J. Virol., 2007, 81, 10362-10378. (Pubitemid 47463311)
9. Li, X.; Sodroski, J. The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. J. Virol., 2008, 82, 11495-11502.
10. Nisole, S.; Stoye., J.P.; Saïb, A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol., 2005, 3, 799-808. (Pubitemid 41518740)
11. Perez-Caballero, D.; Hatziioannou, T.; Yang, A.; Cowan, S.; Bieniasz, P.D. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J. Virol., 2005, 79, 8969-8978. (Pubitemid 40934808)
12. Javanbakht, H.; Yuan, W.; Yeung, D.F.; Song, B.; Diaz-Griffero, F.; Li, Y.; Li, X.; Stremlau, M.; Sodroski, J. Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding. Virology, 2006, 353, 234-246. (Pubitemid 44308489)
13. Stremlau, M.; Perron, M.; Welikala, S.; Sodroski, J. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol., 2005, 79, 3139-3145. (Pubitemid 40270592)
14. Ohkura, S.; Yap, M.W.; Sheldon, T.; Stoye, J.P. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J. Virol., 2006, 80, 8554-8565. (Pubitemid 44384867)
15. Song, B.; Javanbakht, H.; Perron, M.; Parkdo, H.; Stremlau, M.; Sodroski, J. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J. Virol., 2005, 79, 3930-3937. (Pubitemid 40388333)
16. Woo, J.S.; Imm, J.H.; Min, C.K., Kim, K.J., Cha, S.S., Oh, B.H. Structural and functional insights into the B30.2/SPRY domain. EMBO J., 2006, 25, 1353-1363.
17. Li, Y.; Li, X.; Stremlau, M.; Lee, M.; Sodroski, J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J. Virol., 2006, 80, 6738-6744. (Pubitemid 44025173)
18. Diaz-Griffero, F.; Li, X.; Javanbakht, H.; Song, B.; Welikala, S.; Stremlau, M.; Sodroski, J. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology, 2006, 349, 300-315. (Pubitemid 43796239)
19. Asaoka, K.; Ikeda, K.; Hishinuma, T.; Horie-Inoue, K.; Takeda, S.; Inoue, S. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem Biophys Res Commun., 2005, 338, 1950-1956. (Pubitemid 41643112)
20. Decker, T.; Lew, D.J.; Mirkovitch, J.; Darnell, JE. Jr. Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor. EMBO J., 1991, 10, 927-932. (Pubitemid 21905551)
21. Carthagena, L.; Bergamaschi, A.; Luna, J.M.; David, A.; Uchil, P.D.; Margottin-Goguet, F.; Mothes, W.; Hazan, U.; Transy, C.; Pancino, G.; Nisole, S. Human TRIM gene expression in response to interferons. PLoS One., 2009, 4, e4894.
22. Carthagena, L.; Parise, M.C.; Ringeard, M.; Chelbi-Alix, M.K.; Hazan, U; Nisole, S. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology, 2008, 5, 59.
23. O'Connor, C.; Pertel, T.; Gray, S.; Robia, S.L.; Bakowska, J.C.; Luban, J.; Campbell, E.M. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha. J. Virol., 2010, 84, 5997-6006.
24. Song, B.; Diaz-Griffero, F.; Park, D.H.; Rogers, T.; Stremlau, M.; Sodroski, J. TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity. Virology, 2005, 343, 201-211. (Pubitemid 41598361)
25. Garcia-Mata, R.; Gao, Y.S.; Sztul, E. Hassles with taking out the garbage: aggravating aggresomes. Traffic, 2002, 3, 388-396. (Pubitemid 34746406)
26. Newman, R.M.; Johnson, W.E. A brief history of TRIM5alpha. AIDS Rev., 2007, 9, 114-125.
27. Stremlau, M.; Perron, M.; Lee, M.; Li, Y.; Song, B.; Javanbakht, H.; Diaz- Griffero, F.; Anderson, D.J.; Sundquist, W.I.; Sodroski, J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U S A, 2006, 103, 5514-5519.
28. Lim, S.Y.; Rogers, T.; Chan, T.; Whitney, J.B.; Kim, J.; Sodroski, J.; Letvin, N.L. TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys. PLoS. Pathog., 2010, 6, e1000738.
29. Takeuchi, H.; Matano, T. Host factors involved in resistance to retroviral infection. Microbiol. Immunol., 2008, 52, 318-325.
30. Brennan, G.; Kozyrev, Y.; Hu, S.L. TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl. Acad. Sci. U S A, 2008, 105, 3569-3574. (Pubitemid 351723593)
31. Sebastian, S.; Luban, J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology, 2005, 2, 40.
32. Towers, G.J. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology, 2007, 4, 40.
33. Anderson, J.L.; Campbell, E.M.; Wu, X.L.; Vandegraaff, N.; Engelman, A.; Hope, T.J. Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 Proteins. J. Virol., 2006, 80, 9754-9760. (Pubitemid 44435649)
34. Zhang, X.; Kondo, M.; Chen, J.; Miyoshi, H.; Suzuki, H.; Ohashi, T.; Shida, H. Influence of leishmanolysin-like molecules of Herpetomonas samuelpessoai on the interaction with macrophages. Microbes Infect. 2010, 12, 768-777.
35. Hatziioannou T.; Perez-Caballero D.; Yang A.; Cowan S.; Bieniasz P.D. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U S A. 2004, 101, 10774-10779. (Pubitemid 38955818)
36. Ylinen, L.M.; Keckesova, Z.; Wilson, S.J.; Ranasinghe, S.; Towers, G.J. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J. Virol., 2005, 79, 11580-11587. (Pubitemid 41279276)
37. Diehl, W.E.; Stansell, E.; Kaiser, S.M.; Emerman, M.; Hunter, M. Identification of postentry restrictions to Mason-Pfizer monkey virus infection in New World monkey cells. J. Virol., 2008, 82, 11140-11151.
38. Yap, M.W.; Lindemann, D.; Stanke, N.; Reh, J.; Westphal, D.; Hanenberg, H.; Ohkura, S.; Stoye, J.P. Restriction of foamy viruses by primate Trim5alpha. J. Virol., 2008, 82, 5429-5439. (Pubitemid 351705250)
39. Enssle, J.; Fischer, N.; Moebes, A.; Mauer, B.; Smola, U.; Rethwilm, A. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle. J. Virol., 1997, 71, 7312-7317. (Pubitemid 27391669)
40. Wei, B.L.; Denton, P.W.; O'Neill, E.; Luo, T.; Foster, J.L.; Garcia, J.V. Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. J. Virol., 2005, 79, 5705-5712. (Pubitemid 40548239)
41. Yap, M.W.; Nisole, S.; Lynch, C.; Stoye, J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U S A, 2004, 101, 10786-10791. (Pubitemid 38955820)
42. Hatziioannou, T.; Cowan, T.; Schwedler, U.K.; Sundquist, W.I.; Bieniasz, P.D. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J. Virol., 2004, 78, 6005-6012. (Pubitemid 38661688)
43. Strebel, K.; Luban, J.; Jeang, K.T. Human cellular restriction factors that target HIV-1 replication. BMC Med., 2009, 7, 48.
44. Nakayama, E.E.; Shingai, Y.; Kono, K.; Shioda, T. TRIM5alphaindependent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells. Virology, 2008, 375, 514-520.
45. Berthoux, L.; Sebastian, S.; Sokolskaja, E.; Luban, J. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells. Proc. Natl. Acad. Sci., 2005, 102, 14849-14853. (Pubitemid 41457144)
46. Luban, J. Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J. Virol., 2007, 81, 1054-1061. (Pubitemid 46170755)
47. Braaten, D.; Franke, E.K.; Luban, J. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. J. Virol., 1996, 70, 4220-4227.
48. Bosco, D.A.; Eisenmesser, E.Z.; Pochapsky, S.; Sundquist, W.I.; Kern, D. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. USA., 2002, 99, 5247-5252. (Pubitemid 34411534)
49. Kelly B.N.; Howard B.R.; Wang H.; Robinson H.; Sundquist W.I.; Hill C.P. Implications for viral capsid assembly from crystal structures of HIV-1 Gag (1-278) and CA(N)(133-278). Biochemistry, 2006, 45, 11257-11266. (Pubitemid 44453974)
50. Rold, C.J.; Aiken, C. Proteasomal degradation of TRIM5a during Retrovirus Restriction. PLoS. Pathog., 2008, 4, e1000074
51. Thali, M.; Bukovsky, A.; Kondo, E.; Rosenwirth, B.; Walsh, C.T.; Sodroskl, J.; Gottlinger, H.G. Functional association of cyclophilin A with HIV-1 virions. Nature, 1994, 372, 363-365. (Pubitemid 24363438)
52. Franke, E.K.; Yuan, H.E.; Luban, J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature, 1994, 372, 359-363.
53. Sokolskaja, E.; Sayah, D.M.; Luban, J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J. Virol., 2004, 78, 12800-12808. (Pubitemid 39507788)
54. Hatziioannou, T.; Perez-Caballero, D.; Cowan, S.; Bieniasz, P.D. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J. Virol., 2005, 79, 176-183. (Pubitemid 39648375)
55. Kootstra, N.A.; Munk, C.; Tonnu, N.; Landau, N.R.; Verma, I.M. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. U S A, 2003, 100, 1298-1303. (Pubitemid 36183996)
56. Bosco, D.A.; Kern, D. Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs. Biochemistry, 2004, 43, 6110-6119. (Pubitemid 38669479)
57. Keckesova, Z.; Ylinen, M.J.; Towers, G.J. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity. J. Virol., 2006, 80, 4683-4690.
58. Stremlau, M.; Song, B.; Javanbakht, H.; Perron, M.; Sodroski, J. Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. Virology, 2006, 351, 112-120. (Pubitemid 44037658)
59. Lin, T.Y.; Emerman, M. Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1. Virology, 2008, 379, 335-341.
60. Owens, C.M.; Song, B.; Perron, M.J.; Yang, P.C.; Stremlau, M.; Sodroski, J. Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J. Virol., 2004, 78, 5423-5437. (Pubitemid 38581492)
61. Lin, T.Y.; Emerman, M. Cyclophilin A interacts with diverse lentiviral capsids. Retrovirology, 2006, 3, 70.
62. Keele B.F. Identifying and characterizing recently transmitted viruses. Curr. Opin. HIV AIDS., 2010, 5, 327-334.
63. Langelier, C.R.; Sandrin, V.; Eckert, D.M.; Christensen, D.E.; Chandrasekaran, V.; Alam, S.L.; Aiken, C.; Olsen, J.C.; Kar, A.K.; Sodroski, J.G.; Sundquist, W.I. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J. Virol., 2008, 82, 11682-11694.
64. Anderson, J.; Akkina, R. Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue. Hum. Gene. Ther. 2008, 19, 217-228. (Pubitemid 351442727)
65. Anderson, J.; Akkina, R. TRIM5alpharh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages. Mol. Ther., 2005, 12, 687-696. (Pubitemid 41350150)